-
13:30
-13:50
*Small molecules: current position in treatment strategies for inflammatory bowel disease
-
13:50
-14:10
Real-world cost-effectiveness associated with infliximab maintenance therapy
-
14:10
-14:30
When to start a second biologic agents?
-
14:30
-14:50
*The management of postoperative Crohn’s disease
-
14:50
-15:10
Preclinical studies of novel biological agents
-
15:10
-15:30
*Perioperative management of patients with inflammatory bowel disease
New Therapy Forum Novel therapeutic targets by biologics and small molecules
